» Articles » PMID: 15255998

Prolonged Cannabinoid Treatment Results in Spatial Working Memory Deficits and Impaired Long-term Potentiation in the CA1 Region of the Hippocampus in Vivo

Overview
Journal Eur J Neurosci
Specialty Neurology
Date 2004 Jul 17
PMID 15255998
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Adult male Long-Evans rats were administered the potent cannabinoid 1 receptor agonist HU-210 (100 microg/kg, i.p.) for 15 days continuously and their performance on a matching-to-place version of the Morris water maze was subsequently evaluated. Overall, experimental animals performed significantly worse initially on the reference memory component of this task, but their performance improved over 5 days until it was indistinguishable from that of control animals. Animals given HU-210 did not exhibit working memory impairments at short intertrial delays (30 s); however, significant impairments were observed in learning performance with longer intertrial delays (300 s). In vivo electrophysiological analyses revealed that long-term potentiation in the CA1 region of the hippocampus was significantly impaired following the administration of HU-210 for 15 days. These results indicate that long-term cannabinoid exposure can produce marked deficits in reference and working memory performance, and also impair hippocampal synaptic plasticity in vivo.

Citing Articles

Effects of Cannabis on Glutamatergic Neurotransmission: The Interplay between Cannabinoids and Glutamate.

Chowdhury K, Holden M, Wiley M, Suppiramaniam V, Reed M Cells. 2024; 13(13.

PMID: 38994982 PMC: 11240741. DOI: 10.3390/cells13131130.


Chronic pain in Alzheimer's disease: Endocannabinoid system.

Blanton H, Reddy P, Benamar K Exp Neurol. 2022; 360:114287.

PMID: 36455638 PMC: 9789196. DOI: 10.1016/j.expneurol.2022.114287.


Prenatal alcohol and cannabis exposure can have opposing and region-specific effects on parvalbumin interneuron numbers in the hippocampus.

Reid H, Snowden T, Shkolnikov I, Breit K, Rodriguez C, Thomas J Alcohol Clin Exp Res. 2021; 45(11):2246-2255.

PMID: 34523142 PMC: 8642289. DOI: 10.1111/acer.14708.


Potential and Limits of Cannabinoids in Alzheimer's Disease Therapy.

Abate G, Uberti D, Tambaro S Biology (Basel). 2021; 10(6).

PMID: 34204237 PMC: 8234911. DOI: 10.3390/biology10060542.


Molecular neuroscience at its "high": bibliometric analysis of the most cited papers on endocannabinoid system, cannabis and cannabinoids.

Yeung A, Tzvetkov N, Arkells N, Milella L, Stankiewicz A, Huminiecki L J Cannabis Res. 2021; 1(1):4.

PMID: 33526099 PMC: 7815052. DOI: 10.1186/s42238-019-0004-y.